0001447028-22-000011.txt : 20220120
0001447028-22-000011.hdr.sgml : 20220120
20220120175510
ACCESSION NUMBER: 0001447028-22-000011
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220120
FILED AS OF DATE: 20220120
DATE AS OF CHANGE: 20220120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HASTINGS DAVID C
CENTRAL INDEX KEY: 0001237401
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34949
FILM NUMBER: 22543391
MAIL ADDRESS:
STREET 1: C/O ARBUTUS BIOPHARMA
STREET 2: 100-8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arbutus Biopharma Corp
CENTRAL INDEX KEY: 0001447028
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980597776
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 701 VETERANS CIRCLE
CITY: WARMINSTER
STATE: PA
ZIP: 18974
BUSINESS PHONE: 604-419-3200
MAIL ADDRESS:
STREET 1: 701 VETERANS CIRCLE
CITY: WARMINSTER
STATE: PA
ZIP: 18974
FORMER COMPANY:
FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS Corp
DATE OF NAME CHANGE: 20110607
FORMER COMPANY:
FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS CORP
DATE OF NAME CHANGE: 20081003
4
1
wf-form4_164271929611191.xml
FORM 4
X0306
4
2022-01-20
0
0001447028
Arbutus Biopharma Corp
ABUS
0001237401
HASTINGS DAVID C
C/O ARBUTUS BIOPHARMA CORPORATION
701 VETERANS CIRCLE
WARMINSTER
PA
18974
0
1
0
0
Chief Financial Officer
Stock Option (Right to Buy)
2.81
2022-01-20
4
A
0
285000
2.81
A
2032-01-20
Common Shares
285000.0
285000
D
These stock options will vest and become exercisable 1/48th each month over the four year period.
David C Hastings
2022-01-20